A small fraction of tumors with low telomerase activity from liver, lung, mesothelioma, pancreas, stomach, and breast cancers were classified as TGF-β–dominant (C6), consistent with immunosuppressive tumor microenvironments. The gene discussed is TGFB1; the disease is breast cancer.